Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thyroid Hormones in Prematures
NCT02103998Phase 3Withdrawn
- Sponsor
- New York Medical College
- Start
- Jul 2020
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levothyroxine sodium, Potassium iodide in transient hypothyroxinemia of prematurity (THOP), sponsored by New York Medical College. Planned start Jul 2020; status: withdrawn.
02
Drugs
levothyroxine sodiumPotassium iodide
03
Conditions
transient hypothyroxinemia of prematurity (THOP)
Beyond the preview
Go deeper on NCT02103998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02103998.